Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T C Thompson

Showing results (71-80 of 125) with videos related to

Pageof 13
Sort By:
The Journal of Urology|February 26, 1999
Elevated levels of circulating interleukin-6 and transforming growth factor-beta1 in patients with metastatic prostatic carcinomaH L Adler, M A McCurdy, M W Kattan, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 27, 1999
Levels of expression of p27KIP1 protein in human prostate and prostate cancer: an immunohistochemical analysisS Erdamar, G Yang, J W Harper, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 15, 2000
Fenretinide therapy in prostate cancer: effects on tissue and serum retinoid concentrationC Thaller, M Shalev, A Frolov, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|April 1, 1996
Retroviral transduction of transforming growth factor-beta1 induces pleiotropic benign prostatic growth abnormalities in mouse prostate reconstitutionsT L Timme, G Yang, E Rogers, et al.
World Journal of Urology|June 15, 2000
Suicide gene therapy for prostate cancer using a replication-deficient adenovirus containing the herpesvirus thymidine kinase geneM Shalev, B J Miles, T C Thompson, et al.
Cancer Research|October 1, 1993
Dietary fenretinide, a synthetic retinoid, decreases the tumor incidence and the tumor mass of ras+myc-induced carcinomas in the mouse prostate reconstitution model systemK Slawin, D Kadmon, S H Park, et al.
The Journal of Steroid Biochemistry and Molecular Biology|September 1, 1992
Androgen sensitivity and gene expression in ras + myc-induced mouse prostate carcinomasT C Thompson, S Egawa, D Kadmon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2000
Differential expression of nuclear retinoid receptors in normal and malignant prostatesY Lotan, X C Xu, M Shalev, et al.
Cancer|January 15, 1998
Assessment of the biologic markers p53, Ki-67, and apoptotic index as predictive indicators of prostate carcinoma recurrence after surgeryA M Stapleton, P Zbell, M W Kattan, et al.
Human Pathology|August 3, 2000
Cytopathic effect of in situ gene therapy in prostate cancerG Ayala, T M Wheeler, M Shalev, et al.
Pageof 13

Showing results (71-80 of 125) with videos related to

Sort By:
Pageof 13
The Journal of Urology|February 26, 1999
Elevated levels of circulating interleukin-6 and transforming growth factor-beta1 in patients with metastatic prostatic carcinomaH L Adler, M A McCurdy, M W Kattan, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 27, 1999
Levels of expression of p27KIP1 protein in human prostate and prostate cancer: an immunohistochemical analysisS Erdamar, G Yang, J W Harper, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 15, 2000
Fenretinide therapy in prostate cancer: effects on tissue and serum retinoid concentrationC Thaller, M Shalev, A Frolov, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|April 1, 1996
Retroviral transduction of transforming growth factor-beta1 induces pleiotropic benign prostatic growth abnormalities in mouse prostate reconstitutionsT L Timme, G Yang, E Rogers, et al.
World Journal of Urology|June 15, 2000
Suicide gene therapy for prostate cancer using a replication-deficient adenovirus containing the herpesvirus thymidine kinase geneM Shalev, B J Miles, T C Thompson, et al.
Cancer Research|October 1, 1993
Dietary fenretinide, a synthetic retinoid, decreases the tumor incidence and the tumor mass of ras+myc-induced carcinomas in the mouse prostate reconstitution model systemK Slawin, D Kadmon, S H Park, et al.
The Journal of Steroid Biochemistry and Molecular Biology|September 1, 1992
Androgen sensitivity and gene expression in ras + myc-induced mouse prostate carcinomasT C Thompson, S Egawa, D Kadmon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2000
Differential expression of nuclear retinoid receptors in normal and malignant prostatesY Lotan, X C Xu, M Shalev, et al.
Cancer|January 15, 1998
Assessment of the biologic markers p53, Ki-67, and apoptotic index as predictive indicators of prostate carcinoma recurrence after surgeryA M Stapleton, P Zbell, M W Kattan, et al.
Human Pathology|August 3, 2000
Cytopathic effect of in situ gene therapy in prostate cancerG Ayala, T M Wheeler, M Shalev, et al.
Pageof 13